published meta-analysis   sensitivity analysis   studies

hydroxychloroquine in COVID-19 (hospitalized or not) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsWang, 2020 0.96 [0.69; 1.34] 0.96[0.69; 1.34]Wang, 202010%4,165NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-07-04 18:13 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 87 - treatments: 657,832 - roots T: 290